Spots Global Cancer Trial Database for eflornithine

Every month we try and update this database with for eflornithine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy	NCT00086736	Prostate Cancer	bicalutamide eflornithine oral eflornithi... oral bicalutami...	18 Years -	University of Alabama at Birmingham
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus	NCT00003076	Esophageal Canc...	eflornithine	18 Years -	University of Michigan Rogel Cancer Center
Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer	NCT00006101	Prostate Cancer	eflornithine Placebo	35 Years - 70 Years	University of California, Irvine
Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy	NCT00086736	Prostate Cancer	bicalutamide eflornithine oral eflornithi... oral bicalutami...	18 Years -	University of Alabama at Birmingham
Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer	NCT00006101	Prostate Cancer	eflornithine Placebo	35 Years - 70 Years	University of California, Irvine
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis	NCT00033371	Colorectal Canc... Familial Adenom...	Celecoxib Placebo eflornithine Laboratory biom... Questionnaire a...	18 Years - 65 Years	National Cancer Institute (NCI)
Eflornithine To Prevent Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia	NCT00006079	Cervical Cancer Precancerous Co...	Eflornithine Placebo	18 Years -	M.D. Anderson Cancer Center
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma	NCT05717153	Diffuse Glioma Malignant Gliom...	Biospecimen Col... Computed Tomogr... Eflornithine Magnetic Resona... Polyamine Trans... Resection Microdialysis Placement	18 Years -	Mayo Clinic
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients	NCT02796261	Anaplastic Astr... Recurrent Anapl...	Eflornithine Lomustine Lomustine	18 Years -	Orbus Therapeutics, Inc.
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)	NCT01483144	Familial Adenom...	Eflornithine Eflornithine Pl... Sulindac 150 MG Sulindac placeb...	18 Years -	Cancer Prevention Pharmaceuticals, Inc.
Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps	NCT00118365	Precancerous Co...	placebo eflornithine sulindac laboratory biom...	40 Years - 80 Years	National Cancer Institute (NCI)
Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer	NCT00006101	Prostate Cancer	eflornithine Placebo	35 Years - 70 Years	University of California, Irvine
Chemoprevention of Gastric Carcinogenesis	NCT02794428	Gastric Cancer Gastric Intesti...	Eflornithine Eflornithine pl...	30 Years - 69 Years	Vanderbilt-Ingram Cancer Center
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients	NCT02796261	Anaplastic Astr... Recurrent Anapl...	Eflornithine Lomustine Lomustine	18 Years -	Orbus Therapeutics, Inc.
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)	NCT01483144	Familial Adenom...	Eflornithine Eflornithine Pl... Sulindac 150 MG Sulindac placeb...	18 Years -	Cancer Prevention Pharmaceuticals, Inc.
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer	NCT00983580	Adenomatous Pol...	Aspirin Eflornithine Laboratory Biom... Placebo Telephone-Based...	40 Years -	National Cancer Institute (NCI)
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis	NCT00033371	Colorectal Canc... Familial Adenom...	Celecoxib Placebo eflornithine Laboratory biom... Questionnaire a...	18 Years - 65 Years	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: